Discovery and structure-activity relationships (SAR) of a novel class of 2-substituted N-piperidinyl indole-based nociceptin opioid receptor ligands

被引:2
|
作者
Meyer, Michael E. [1 ]
Doshi, Arpit [1 ]
Polgar, Willma E. [1 ]
Zaveri, Nurulain T. [1 ]
机构
[1] Astraea Therapeut LLC, 320 Logue Ave,Suite 142, Mountain View, CA 94043 USA
关键词
Nociceptin opioid receptor; mu opioid receptor; N/OFQ; NOP; MOP; Nociceptin full agonist; Nociceptin partial agonist; Bifunctional agonist; Structure -based drug design; Structure activity relationship; G -protein coupled receptor; Orthosteric binding site; CONDITIONED PLACE PREFERENCE; ORPHANIN FQ RECEPTOR; TISSUE DISTRIBUTION; MOLECULAR-CLONING; NOP; MEMBER; AGONIST; BINDING; ORL1; ACQUISITION;
D O I
10.1016/j.bmc.2023.117421
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The development of SAR around substituted N-piperidinyl indole-based nociceptin opioid receptor (NOP) ligands led to the discovery of a novel series of 2-substituted N-piperidinyl indoles that provide both selective NOP full agonists and bifunctional NOP full agonists-& mu; opioid (MOP) receptor partial agonists. 2-substituted N-piperidinyl indoles have improved potency at the NOP receptor and are NOP full agonists, compared to our previously reported 3-substituted N-piperidinyl indoles that are selective NOP partial agonists. SAR in this series of 2 -substituted N-piperidinyl indoles shows that 2-substitution versus 3-substitution on the indole moiety affects their intrinsic activity and opioid receptor selectivity. Molecular docking of these 2-substituted N-piperidinyl indoles in an active-state NOP homology model and MOP receptor structures provides a rationale for the dif-ferences observed in the binding, functional profiles and selectivity of 2-substituted versus 3-substituted N-piperidinyl indoles.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Discovery of 1-(β-amino substituted-β-alanyl)-N,N-dimethylindoline-2-carboxamides as novel nonpeptide antagonists of nociceptin/orphanin FQ receptor: Efficient design, synthesis, and structure-activity relationship studies
    Hayashi, Shigeo
    Ohashi, Katsuyo
    Nakata, Eriko
    Emoto, Chie
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 : 228 - 242
  • [32] Factors influencing agonist potency and selectivity for the opioid δ receptor are revealed in structure-activity relationship studies of the 4-[(N-substituted-4-piperidinyl) arylamino]-N,N-diethylbenzamides
    Thomas, JB
    Herault, XM
    Rothman, RB
    Atkinson, RN
    Burgess, JP
    Mascarella, SW
    Dersch, CM
    Xu, H
    Flippen-Anderson, JL
    George, CF
    Carroll, FI
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (06) : 972 - 987
  • [33] Discovery of pyridine-2-ones as novel class of multidrug resistance (MDR) modulators: First structure-activity relationships
    Krawczyk, Soeren
    Otto, Monika
    Otto, Alexander
    Coburger, Claudius
    Krug, Martin
    Seifert, Marianne
    Tell, Volkmar
    Molnar, Josef
    Hilgeroth, Andreas
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (21) : 6309 - 6315
  • [34] Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization
    Zirimwabagabo, Jean-Olivier
    Jailani, Ameera B. A.
    Avgoustou, Paris
    Tozer, Matthew J.
    Gibson, Karl R.
    Glossop, Paul A.
    Mills, James E. J.
    Porter, Roderick A.
    Blaney, Paul
    Wang, Ning
    Skerry, Timothy M.
    Richards, Gareth O.
    Harrity, Joseph P. A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (06) : 3299 - 3319
  • [35] Structure-activity relationships for a novel series of dopamine D2-like receptor ligands based on N-substituted 3-aryl-8-azabicyclo[3.2.1]octan-3-ol
    Paul, Noel M.
    Taylor, Michelle
    Kumar, Rakesh
    Deschamps, Jeffrey R.
    Luedtke, Robert R.
    Newman, Amy Hauck
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (19) : 6095 - 6109
  • [36] Structure-activity relationships of 2,N6,5′-substituted adenosine derivatives with potent activity at the A2B adenosine receptor
    Adachi, Hayamitsu
    Palaniappan, Krishnan K.
    Ivanov, Andrei A.
    Bergman, Nathaniel
    Gao, Zhan-Guo
    Jacobson, Kenneth A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (08) : 1810 - 1827
  • [37] Design, synthesis, and structure-activity relationships of novel 2-substituted pyrazinoylguanidine epithelial sodium channel blockers: Drugs for cystic fibrosis and chronic bronchitis
    Hirsh, Andrew J.
    Molino, Bruce F.
    Zhang, Jianzhong
    Astakhova, Nadezhda
    Geiss, William B.
    Sargent, Bruce J.
    Swenson, Brian D.
    Usyatinsky, Alexander
    Wyle, Michael J.
    Boucher, Richard C.
    Smith, Rick T.
    Zamurs, Andra
    Johnson, M. Ross
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (14) : 4098 - 4115
  • [38] Design, syntheses, structure-activity relationships and docking studies of coumarin derivatives as novel selective ligands for the CB2 receptor
    Han, Shuang
    Zhang, Fei-Fei
    Qian, Hai-Yan
    Chen, Li-Li
    Pu, Jian-Bin
    Xie, Xin
    Chen, Jian-Zhong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 93 : 16 - 32
  • [39] Discovery of substituted 1,4-dihydroquinolines as novel promising class of P-glycoprotein inhibitors: First structure-activity relationships and bioanalytical studies
    Hemmer, Marc
    Krawczyk, Soeren
    Simon, Ina
    Hilgeroth, Andreas
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (15) : 3005 - 3008
  • [40] 4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives
    Catarzi, Daniela
    Varano, Flavia
    Vigiani, Erica
    Calenda, Sara
    Melani, Fabrizio
    Varani, Katia
    Vincenzi, Fabrizio
    Pasquini, Silvia
    Mennini, Natascia
    Nerli, Giulia
    Dal Ben, Diego
    Volpini, Rosaria
    Colotta, Vittoria
    PHARMACEUTICALS, 2022, 15 (04)